S100A11 and glioblastoma: Regarding the involvement of these proteins in the aggressiveness of the glioma, we identified that a high expression of S100A9 and S100A11 was associated with a significant decrease in the survival of patients with IDH wt tumors (TCGA LGG+GBM), suggesting a most unfavourable prognosis for these patients.